Abstract:Extracellular signal-regulated kinases (ERKs) activity is regulated by MAPK/ERK kinases (MEKs), which phosphorylate the regulatory Tyr and Thr residues in ERKs activation loop, and by various phosphatases that remove the incorporated phosphates. Although the role of the phosphorylated residues in the activation loop of ERKs is well studied, much less is known about the role of other residues within this loop. Here we substituted several residues within amino acids 173-177 of ERK2 and studied their role in ERK2… Show more
“…Phosphorylation of protein kinases is known to regulate their cellular distribution and their import/export from the nucleus (45)(46)(47)(48). Phosphorylation of GSK-3␣ at serine 21, located within its N-terminal region, inhibits its kinase activity via its ability to function as a pseudosubstrate (49,50).…”
Section: Figure 2 Deletion Of the N-terminal Region Of Gsk-3␣ Resultmentioning
Glycogen synthase kinase-3 (GSK-3) is expressed as two isozymes ␣ and . They share high similarity in their catalytic domains but differ in their N-and C-terminal regions, with GSK-3␣ having an extended glycine-rich N terminus. Here, we undertook live cell imaging combined with molecular and bioinformatic studies to understand the distinct functions of the GSK-3 isozymes focusing on GSK-3␣ N-terminal region. We found that unlike GSK-3, which shuttles between the nucleus and cytoplasm, GSK-3␣ was excluded from the nucleus. Deletion of the N-terminal region of GSK-3␣ resulted in nuclear localization, and treatment with leptomycin B resulted in GSK-3␣ accumulation in the nucleus. GSK-3␣ rapidly accumulated in the nucleus in response to calcium or serum deprivation, and accumulation was strongly inhibited by the calpain inhibitor calpeptin. This nuclear accumulation was not mediated by cleavage of the N-terminal region or phosphorylation of GSK-3␣. Rather, we show that calcium-induced GSK-3␣ nuclear accumulation was governed by GSK-3␣ binding with as yet unknown calpain-sensitive protein or proteins; this binding was mediated by the N-terminal region. Bioinformatic and experimental analyses indicated that nuclear exclusion of GSK-3␣ was likely an exclusive characteristic of mammalian GSK-3␣. Finally, we show that nuclear localization of GSK-3␣ reduced the nuclear pool of -catenin and its target cyclin D1. Taken together, these data suggest that the N-terminal region of GSK-3␣ is responsible for its nuclear exclusion and that binding with a calcium/calpain-sensitive product enables GSK-3␣ nuclear retention. We further uncovered a novel link between calcium and nuclear GSK-3␣-mediated inhibition of the canonical Wnt/-catenin pathway.
“…Phosphorylation of protein kinases is known to regulate their cellular distribution and their import/export from the nucleus (45)(46)(47)(48). Phosphorylation of GSK-3␣ at serine 21, located within its N-terminal region, inhibits its kinase activity via its ability to function as a pseudosubstrate (49,50).…”
Section: Figure 2 Deletion Of the N-terminal Region Of Gsk-3␣ Resultmentioning
Glycogen synthase kinase-3 (GSK-3) is expressed as two isozymes ␣ and . They share high similarity in their catalytic domains but differ in their N-and C-terminal regions, with GSK-3␣ having an extended glycine-rich N terminus. Here, we undertook live cell imaging combined with molecular and bioinformatic studies to understand the distinct functions of the GSK-3 isozymes focusing on GSK-3␣ N-terminal region. We found that unlike GSK-3, which shuttles between the nucleus and cytoplasm, GSK-3␣ was excluded from the nucleus. Deletion of the N-terminal region of GSK-3␣ resulted in nuclear localization, and treatment with leptomycin B resulted in GSK-3␣ accumulation in the nucleus. GSK-3␣ rapidly accumulated in the nucleus in response to calcium or serum deprivation, and accumulation was strongly inhibited by the calpain inhibitor calpeptin. This nuclear accumulation was not mediated by cleavage of the N-terminal region or phosphorylation of GSK-3␣. Rather, we show that calcium-induced GSK-3␣ nuclear accumulation was governed by GSK-3␣ binding with as yet unknown calpain-sensitive protein or proteins; this binding was mediated by the N-terminal region. Bioinformatic and experimental analyses indicated that nuclear exclusion of GSK-3␣ was likely an exclusive characteristic of mammalian GSK-3␣. Finally, we show that nuclear localization of GSK-3␣ reduced the nuclear pool of -catenin and its target cyclin D1. Taken together, these data suggest that the N-terminal region of GSK-3␣ is responsible for its nuclear exclusion and that binding with a calcium/calpain-sensitive product enables GSK-3␣ nuclear retention. We further uncovered a novel link between calcium and nuclear GSK-3␣-mediated inhibition of the canonical Wnt/-catenin pathway.
“…Phosphorylation is a reversible and therefore, economical process for the cell: the dynamic interconversion between differentially phosphorylated and dephosphorylated forms of the same protein has the potential to increase the number of possible signaling outcomes without increasing the number of proteins required [58,59]. For example, phosphorylation of the MAPKs Erk1/2 by MEK results in signaling conducive to cell proliferation, survival and adhesion, whereas their dephosphorylation by MAPK phosphatases (MKPs) like MKP-1, has been shown to induce apoptosis [57].…”
To my entire family: for your loving support and tireless encouragement, I dedicate this work to you.iii Acknowledgements:
Abstract:The precise mechanism regulating focal adhesion disassembly has yet to be elucidated.
Recently
“…Importantly, other residues in close proximity to the activation loop of ERK1/2 are phosphorylated as well 67 and thereby may affect this important region of ERK1/2. 68 Notably, these Thr-Glu-Tyr-independent phosphorylations are usually not important merely for the activation mechanisms of ERK1/2 but rather play a role in the regulation of ERK1/2 localization or downregulation and thereby in the determination of their signaling specificity, as described below.…”
Section: Regulation Of Erk1/2 By Kinases and Phosphatasesmentioning
The extracellular signal-regulated kinase 1/2 (ERK1/2) cascade is a central signaling pathway that regulates a wide variety of stimulated cellular processes, including mainly proliferation, differentiation, and survival, but apoptosis and stress response as well. The ability of this linear cascade to induce so many distinct and even opposing effects after various stimulations raises the question as to how the signaling specificity of the cascade is regulated. Over the past years, several specificity-mediating mechanisms have been elucidated, including temporal regulation, scaffolding interactions, crosstalks with other signaling components, substrate competition, and multiple components in each tier of the cascade. In addition, spatial regulation of various components of the cascade is probably one of the main ways by which signals can be directed to some downstream targets and not to others. In this review, we describe first the components of the ERK1/2 cascade and their mode of regulation by kinases, phosphatases, and scaffold proteins. In the second part, we focus on the role of MEK1/2 and ERK1/2 compartmentalization in the nucleus, mitochondria, endosomes, plasma membrane, cytoskeleton, and Golgi apparatus. We explain that this spatial distribution may direct ERK1/2 signals to regulate the organelles' activities. However, it can also direct the activity of the cascade's components to the outer surface of the organelles in order to bring them to close proximity to specific cytoplasmic targets. We conclude that the dynamic localization of the ERK1/2 cascade components is an important regulatory mechanism in determining the signaling specificity of the cascade, and its understanding should shed a new light on the understanding of many stimulus-dependent processes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.